Kazushige Mori
- Oncology top 1%
- HER2/EGFR in Cancer Research 7
- Colorectal Cancer Treatments and Studies 7
- Cancer Treatment and Pharmacology 6
- Peptidase Inhibition and Analysis 4
- Cancer Research top 5%
- Electrochemistry top 5%
- Dermatology top 2%
- Hepatology top 5%
-
- Electrochemical sensors and biosensors 8
-
- Lung Cancer Treatments and Mutations 5
-
- Enzyme Catalysis and Immobilization 4
-
- Analytical Chemistry and Sensors 4
- Co-authors
- Hideo IshitsukaNoriaki SawadaMasanori MiwaM NishidaMasako UraNobuo ShimmaT IshikawaIsao UMEDA
- Journals
- Journal of Clinical Oncology (1 paper)Cancer Research (1 paper)Scientific Reports (1 paper)
- Partner nations
- JapanUnited StatesSwitzerland
In The Last Decade
Kazushige Mori
50 papers receiving 2.9k citations
Hit Papers
Peers
Comparison fields: 5 of 104
- Oncology 1.9k
- Cancer Research 457
- Electrochemistry 152
- Dermatology 195
- Hepatology 152
Countries citing papers authored by Kazushige Mori
This map shows the geographic impact of Kazushige Mori's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kazushige Mori with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kazushige Mori more than expected).
Fields of papers citing papers by Kazushige Mori
This network shows the impact of papers produced by Kazushige Mori. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kazushige Mori. The network helps show where Kazushige Mori may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Kazushige Mori, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 22 | |
| 2 | 2018 | 43 | |
| 3 | 2018 | 19 | |
| 4 | 2016 | 24 | |
| 5 | 2015 | 30 | |
| 6 | 2015 | 103 | |
| 7 | 2012 | 39 | |
| 8 | 2012 | 24 | |
| 9 | 2011 | 36 | |
| 10 | 2011 | 12 | |
| 11 | 2010 | 51 | |
| 12 | 2010 | 17 | |
| 13 | 2010 | 5 | |
| 14 | 2010 | 11 | |
| 15 | 2009 | 18 | |
| 16 | 2006 | 163 | |
| 17 | 2006 | 14 | |
| 18 | 2004 | 34 | |
| 19 | Design of a novel oral fluoropyrimidine carbamate, capecitabine, which generates 5-fluorouracil selectively in tumours by enzymes concentrated in human liver and cancer tissuebreakdown → | 1998 | 1039 |
| 20 | 1996 | 37 |
About Kazushige Mori
Kazushige Mori is a scholar working on Oncology, Bioengineering and Biochemistry, having authored 50 papers that have together received 3.0k indexed citations. Recurring topics across this work include Electrochemical sensors and biosensors (8 papers), HER2/EGFR in Cancer Research (7 papers), Colorectal Cancer Treatments and Studies (7 papers), Cancer Treatment and Pharmacology (6 papers), Lung Cancer Treatments and Mutations (5 papers), Enzyme Catalysis and Immobilization (4 papers), Peptidase Inhibition and Analysis (4 papers) and Analytical Chemistry and Sensors (4 papers). The work is most often cited by research in Oncology (1.9k citations), Cancer Research (457 citations) and Electrochemistry (152 citations). Kazushige Mori has collaborated with scholars based in Japan, United States and Switzerland. Frequent co-authors include Hideo Ishitsuka, Noriaki Sawada, Masanori Miwa, M Nishida, Masako Ura, Nobuo Shimma, T Ishikawa, Isao UMEDA, Kaori Fujimoto-Ouchi and Koji Sode. Their work appears in journals such as Journal of Clinical Oncology, Cancer Research and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.